8888 Federal Register / Vol. 80, No. 33 / Thursday, February 19, 2015 / Notices 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Pediatric Cardiac Genomics Consortium. 

Date: March 11, 2015. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Garden Inn Washington DC/ 

Bethesda, 7301 Waverly Street, Bethesda, MD 

20814. 

Contact Person: YingYing Li-Smerin, MD, 

Ph.D, Scientific Review Officer, Office of 

Scientific Review/DERA, National Heart, 

Lung, and Blood Institute, 6701 Rockledge 

Drive, Room 7184, Bethesda, MD 20892– 

7924, 301–435–0277, lismerin@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: February 12, 2015. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–03345 Filed 2–18–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S. C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S. 

C., as amended. The grant applications 

and the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Sensorimotor Integration. 

Date: March 10–11, 2015. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD (Virtual 

Meeting). 

Contact Person: Kirk Thompson, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5184, 

MSC 7844, Bethesda, MD 20892, 301–435– 

1242, kgt@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Adult Psychopathology and 

Disorders of Aging. 

Date: March 17, 2015. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Andrea B Kelly, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3182, 

MSC 7770, Bethesda, MD 20892, (301) 455– 

1761, kellya2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Pain. 

Date: March 19–20, 2015. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: John Bishop, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7844, Bethesda, MD 20892, (301) 408– 

9664, bishopj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, RFA Panel: 

Molecular and Cellular Substrates of 

Complex Brain Disorders. 

Date: March 23, 2015. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crystal Gateway Marriott, 1700 

Jefferson Davis Highway, Arlington, VA 

22202. 

Contact Person: Deborah L Lewis, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4183, 

MSC 7850, Bethesda, MD 20892, 301–408– 

9129, lewisdeb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR–13– 

231: Phenotyping Embryonic Lethal 

Knockout Mice. 

Date: March 24, 2015. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Maqsood A Wani, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2114, 

MSC 7814, Bethesda, MD 20892, 301–435– 

2270, wanimaqs@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR–13– 

231: Phenotyping Embryonic Lethal 

Knockout Mice. 

Date: March 24, 2015. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Arnold Revzin, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4146, 

MSC 7824, Bethesda, MD 20892, (301) 435– 

1153, revzina@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Molecular Genetics. 

Date: March 24, 2015. 

Time: 2:30 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20817, 

(Telephone Conference Call). 

Contact Person: Ronald Adkins, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2206, 

MSC 7890, Bethesda, MD 20892, 301–435– 

4511, ronald.adkins@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, RFA–RM– 

14–012: Common Fund Glycoscience Data 

Integration and Analysis, Tools (R34). 

Date: March 25, 2015. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Kee Hyang Pyon, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5148, 

MSC 7806, Bethesda, MD 20892, pyonkh2@

csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Auditory Neuroscience. 

Date: March 26–27, 2015. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: John Bishop, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7844, Bethesda, MD 20892, (301) 408– 

9664, bishopj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, RFA–RM– 

14–013: Development of Glycoscience Tools 

(U01). 

Date: March 26, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 


emcdonald on DSK67QTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 33 / Thursday, February 19, 2015 / Notices 8889 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: James J Li, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 5148, MSC 7849, Bethesda, MD 

20892, 301–806–8065, lijames@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Metabolism, Nutrition and 

Molecular Endocrinology. 

Date: March 26, 2015. 

Time: 8:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Dianne Hardy, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6175, 

MSC 7892, Bethesda, MD 20892, 301–435– 

1154, dianne.hardy@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SBIR/STTR 

Informatics. 

Date: March 26, 2015. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: JW Marriott New Orleans, 614 Canal 

Street, New Orleans, LA 70130. 

Contact Person: Melinda Jenkins, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3156, 

MSC 7770, Bethesda, MD 20892, 301–437– 

7872, jenkinsml2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 12, 2015. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–03343 Filed 2–18–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Cancer Institute Board of 

Scientific Advisors. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The meeting 

will also be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting Web site (http:// 

videocast.nih.gov/). 

Name of Committee: National Cancer 

Institute Board of Scientific Advisors. 

Date: March 11, 2015. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: Director’s Report: Ongoing and 

New Business; Reports of Program Review 

Group(s); Budget Presentations; Reports of 

Special Initiatives; RFA and RFP Concept 

Reviews; and Scientific Presentations. 

Place: National Institutes of Health, 31 

Center Drive, Building 31; C-Wing, 6th Floor, 

Room 10, Bethesda, MD 20892. 

Contact Person: Paulette S. Gray, Ph.D., 

Director, Division of Extramural Activities, 

National Cancer Institute—Shady Grove, 

National Institutes of Health, 9609 Medical 

Center Drive, 7th Floor, Rm. 7w444 Bethesda, 

MD 20892, 240–276–6340, 

grayp@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

deainfo.nci.nih.gov/advisory/bsa/bsa.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: February 12, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–03346 Filed 2–18–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2015–0007] 

Cooperative Research and 

Development Agreement—Robotic 

Aircraft for Maritime Public Safety 

AGENCY: Coast Guard, DHS. 

ACTION: Notice of intent; request for 

comments. 

SUMMARY: The Coast Guard announces 

its intent to enter into a cooperative 

research and development agreement 

(CRADA) with several companies to 

evaluate small unmanned aircraft 

systems (SUAS) and their airborne 

sensors, to determine their potential for 

use in a maritime environment by a first 

responder and DHS operational 

components. The Coast Guard will 

conduct flight testing and evaluation of 

SUAS under a wide variety of simulated 

but realistic and relevant real-world 

maritime operational scenarios, such as 

law enforcement, search and rescue, and 

maritime environmental response. 

While the Coast Guard is currently 

considering partnering with Aerovel 

Corporation, Aerovironment Inc., 

Aurora Flight Sciences, Lockheed 

Martin Corporation, and Mission 

Technology Systems LLC, it solicits 

public comment on the possible 

participation of other parties in the 

proposed CRADA, and the nature of that 

participation. The Coast Guard also 

invites other potential non-Federal 

participants, who have the interest and 

capability to bring similar contributions 

to this type of research, to consider 

submitting proposals for consideration 

in similar CRADAs. 

DATES: Comments must be submitted to 

the online docket via http://

www.regulations.gov, or reach the 

Docket Management Facility, on or 

before March 23, 2015. 

Synopses of proposals regarding 

future CRADAs must reach the Coast 

Guard (see FOR FURTHER INFORMATION

CONTACT) on or before March 23, 2015. 

ADDRESSES: Submit comments using one 

of the listed methods, and see 

SUPPLEMENTARY INFORMATION for more 

information on public comments. 

• Online—http://www.regulations.gov 

following Web site instructions. 

• Fax—202–493–2251. 

• Mail or hand deliver—Docket 

Management Facility (M–30), U.S. 

Department of Transportation, West 

Building Ground Floor, Room W12–140, 

1200 New Jersey Avenue SE., 

Washington, DC 20590–0001. Hours for 


emcdonald on DSK67QTVN1PROD with NOTICES